Healthcare PharmaceuticalsEntyvio
Owned by Takeda Pharmaceutical Company
Prescription biologic medication for treating inflammatory bowel disease, including Crohn's disease and ulcerative colitis. Takeda's top-selling product, generating over $5 billion annually.
gastroenterologyinflammatory-bowel-diseasecrohns-disease